FDA cracking down on fat-melting injections

Apr 07, 2010 By MATTHEW PERRONE , AP Business Writer

(AP) -- The Food and Drug Administration is cracking down on fat-melting injections used in spas across the U.S., saying the drugs have not been proven safe or effective.

Lipodissolve injections, a popular nonsurgical alternative to liposuction, are used to dissolve small fat deposits around the legs, arms and belly. The FDA said Wednesday the drugs have not been cleared by federal scientists, as required by law.

The agency issued warning letters to a half-dozen spas that offer the injections, citing them for making unsubstantiated claims about lipodissolve therapy.

"The claims made for your lipodissolve products are false and misleading in that they are not supported by substantial evidence or substantial clinical experience," states a letter to All About You Medspa in Madison, Ind.

Other spas cited by the FDA included: Pure Med Spa of Boca Raton, Fla., Monarch Med Spa of King of Prussia, Pa., and three others.

The Web site for Monarch Med Spa claims that, "Rather than go through the pain and discomfort associated with liposuction, patients now have the option of a series of injections with very minimal discomfort."

Calls to Monarch Med Spa were not immediately returned midday Wednesday.

FDA regulators called on the spas to stop using such claims and notify the agency within 15 working days of steps they are taking to correct the violations.

Spas that offer the injections say they are safe and effective. But safety advocates have called for proof and urge patients to think twice before paying thousands of dollars for an unproven procedure.

Some patients have complained of swelling, hard lumps and dark spots on their skin after receiving the therapy.

Lipodissolve and similar treatments use two chemicals, phosphatidylcholine, or PC, and sodium dioxycholate, or DC. Injections with the PC/DC mix aren't a treatment for obesity but a way to dissolve deposits of fat in certain areas.

Explore further: New gel medication breakthrough delays release of drug to benefit the patient

0 shares

Related Stories

FDA sends Procter & Gamble a warning

Sep 18, 2007

The U. S. Food and Drug Administration has warned the Procter & Gamble Co. about claims it makes for its Vicks Early Defense Foaming Hand Sanitizer.

Millennials' medspa influence

Jun 24, 2008

[B]Women ages 18-34 are empowering the medical spa trend but doing little to advocate their own safety within the facility[/B] The American Academy of Cosmetic Surgery has released its results from a consumer survey ask ...

FDA concerned about some STD medications

Mar 10, 2008

The U.S. Food and Drug Administration has warned six companies to stop marketing unapproved drugs for treating and preventing sexually transmitted diseases.

Recommended for you

Rising antibiotic shortages raise concerns about patient care

Apr 23, 2015

Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Di ...

Study supports HPV vaccination guidelines

Apr 21, 2015

(HealthDay)—New research finds that young women who get the HPV vaccine gain significant protection against infection in three parts of the body if they haven't already been exposed to the human papillomavirus.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.